Dr. Hernan Antonio Bazan, MD

Dr. Bazan practices at 3883 Airway Drive Imaging in Santa Rosa, California.

Dr. Bazan's NPI, 1073714358, was assigned on May 31, 2007. Dr. Bazan graduated from Georgetown University School Of Medicine in 2000. Dr. Bazan holds Louisiana license 201525.

Dr. Bazan's primary practice is 3883 Airway Drive Imaging, at 3883 Airway Dr. Ste 100, Santa Rosa, CA 95403. The practice phone is (707) 521-4480.

Dr. Bazan's primary practice is 3883 Airway Drive Imaging in Santa Rosa, California. Dr. Bazan is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Bazan to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Bazan's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bazan practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Bazan's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Bazan is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Bazan's licenses on file in 2 states: Louisiana and Connecticut.

Dmand AI lists blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization, peripheral vascular disease, varicose veins and varicose vein treatment among the conditions Dr. Bazan treats.

CMS data shows 299 Medicare services from Dr. Bazan across 9 procedure codes in 2024, for 198 Medicare patients. Medicare paid $16,486 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 198 Medicare patients who saw Dr. Bazan in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bazan's median patient age at 67, with 42% women.

In 2024, Dr. Bazan wrote 241 Medicare Part D claims for 85 patients. 94% of them were for generic drugs. CMS names the drug for 198 of them, across 4 drugs with 11 or more claims each, at $8,386 in total drug cost. In 2023, CMS named 150 claims across 3 drugs.

Dr. Bazan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 54 papers to Dr. Bazan, published from 2008 to 2025. 2015 was the busiest year, with 7. The most frequent topics are Endarterectomy, Carotid, Stents and Carotid Stenosis. Dr. Bazan has published most often in J Vasc Surg. Dr. Bazan's most frequent co-authors are Waldemar C. Sternbergh, MD, Taylor Andrew Smith, MD and Clayton Joseph Brinster, MD.

Dmand AI links Dr. Bazan to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Carotid Artery Diseases, Carotid Stenosis and Gangrene.

CMS Open Payments shows 134 general payments to Dr. Bazan from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. W. L. Gore & Associates, Inc. paid the most, $5,734.

Dmand AI lists 5 awards for Dr. Bazan, most recently Top Doctor in Vascular Surgery in 2024.

Dr. Bazan graduated from Georgetown University School Of Medicine in 2000. Dr. Bazan is a member of AOA, ACS, BIO, SVS, SAVS and Yale Surgical Society.

Dr. Bazan is in network with 12 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.